Outcomes analysis in congenital diaphragmatic hernia (CDH) requires a validated risk-adjustment tool. The purpose of this study was to use the Canadian Neonatal Network (CNN) database to validate the Score for Neonatal Acute Physiology, Version II (SNAP-II) for prediction of mortality among CDH infants admitted to a neonatal intensive care unit (NICU), and to compare this to the predictive equation recently developed by the Congenital Diaphragmatic Hernia Study Group (CDHSG).
BACKGROUND
Congenital diaphragmatic hernia (CDH) is a relatively infrequent condition with variable illness severity that usually requires complex, multidisciplinary care, including surgery, neonatal intensive care and sometimes, extracorporeal membrane oxygenation (ECMO). A validated instrument of mortality-risk adjustment for CDH is necessary to allow comparisons of outcome within and between centres, and for the design of prospective studies that might evaluate the effects of specific treatment strategies on outcome. The Congenital Diaphragmatic Hernia Study Group (CDHSG) recently published a logistic regression equation using birth weight and 5-minute Apgar score to predict risk of mortality among infants with CDH. 1 Model predictive performance and goodness-of-fit were not reported. Richardson et al. 2 previously developed and validated the Score for Neonatal Acute Physiology, Version II (SNAP-II) for predicting mortality and morbidity among neonates admitted to the neonatal intensive care unit (NICU). SNAP-II is a neonatal illness severity score calculated from six empirically weighted physiologic measurements made during the first 12 hours of admission to the NICU. Our objectives were to assess the ability of admission SNAP-II score to predict mortality among infants with CDH admitted to the NICU and to compare its predictive performance and model goodness-of-fit with the CDHSG method.
METHODS
The Canadian Neonatal Network (CNN), established in 1995, and comprising 17 tertiary perinatal centers that geographically represent all regions in Canada, has been described previously. 3 Thirteen of the 17 centers function as regionally serving perinatal/ neonatal centers, while four centers admit only outborn infants. Pediatric surgical subspecialty coverage (including general surgery and neurosurgery), and pediatric anesthesia are available in 14 hospitals, and pediatric cardiac surgery and ECMO support are available in nine and four hospitals, respectively. Considered together, the 17 CNN centers account for 75% of Canadian level III neonatal nursery beds.
Study Population
The study population for this report consists of all 20,488 admissions to the 17 participating CNN centers during a 22-month period (January 1996 to October 1997). An NICU admission was defined as an NICU stay of at least 24 hours duration, or death or transfer to another NICU within 24 hours. Patients not discharged from hospital by the study closure date (June 30, 1998) were excluded (n ¼ 11). If infants were readmitted following discharge or transfer, their data were linked to their first admission. After accounting for readmissions and transfers, there were a total of 19,507 infants treated via 20,488 admissions.
Data Abstraction
With institutional review board (IRB) approval, patient information was abstracted daily from clinical charts on site. Data were entered into a customized data entry program with built-in error checking, and transmitted electronically to the Centre for Healthcare Innovation and Improvement (CHII) where accuracy of recording was verified and analysis conducted. Thereafter, data were managed by a geographically representative steering committee comprised of researchers and neonatologists.
CDH Patients: Population Risk Variables and Specific Outcomes
All patients with an ICD-10 diagnostic code 756.6 (anomalies of the diaphragm) who survived long enough to be admitted to an NICU were included in this study. 4 Maternal information included demographics, antenatal history (prenatal care, history of maternal hypertension, history of previous Cesarean section, multiple births, birth presentation, use of antenatal steroids), mode of delivery, and whether the infant was inborn or outborn. Infant characteristics included gender, birth weight, associated congenital anomalies, 5-minute Apgar score and day of admission illness severity score (SNAP-II: see definition). Outcome was defined as either death or survival to discharge from the NICU.
Definition of Terms
Score for Neonatal Acute Physiology version II (SNAP-II) 2 is a standardized, clinically validated index, which records illness severity in terms of the degree of derangement from the physiological norm for six physiologic parameters (lowest blood pressure, lowest temperature, PO 2 /FiO 2 ratio, lowest serum pH, seizures, and urine output) over 12 hours. The final cumulative score recorded is independent of the actual diagnosis.
Data Analysis
Descriptive statistics: Population risk variables (including admission SNAP-II score) and outcomes were recorded for CDH patients from the CNN database. Bivariate analysis was used to test correlation between population risk variables and the outcome (mortality).
Discrimination: Population risk variables significantly (P<0.05) correlated with the outcomes on bivariate analysis were entered into multivariable logistic regression analyses to model outcomes. Predictive variables from multivariable logistic regression modelling were then tested individually and in combination using the receiver operator characteristic (ROC) curve technique of Hanley and McNeil 5 to assess model prediction of outcomes. The area under the ROC curve (AUC) depicts model discrimination. For example, when admission SNAP-II is used to predict mortality, the AUC relates the probability of a patient who died having a higher admission SNAP-II score than a patient who survived. An AUC of 0.5 is completely random whereas an AUC of 1.0 indicates perfect discrimination. In addition to modelling outcomes with our own predictive variables, we tested the performance of the CDHSG predictive model, where: Probability of survival ¼ 1À1/(1 þ e Àx ) where Àx ¼ À5.0240 þ 0.9165 (birthweight in kilograms) þ 0.4512 (Apgar score at 5 minutes).
Calibration: We used the technique of Hosmer-Lemeshow 6 to test the goodness-of-fit between observed and expected outcomes. A p-value of >0.05 indicates no significant difference between the observed and expected values (i.e. the model fit is acceptable). A higher p-value indicates a better goodness-of-fit. Table 1 summarizes the risk variables of the 88 CDH patients from the CNN database. Infants were born near term (one-third by Cesarean section) with a mean gestational age of 37 weeks. Greater than 50% of CDH infants were outborn, although many of these births occurred in a nearby maternity hospital that is functionally linked to the treating children's hospital. The frequency with which a prenatal diagnosis of CDH was made could not be determined by the database. The mean admission SNAP II score was 17.6±16.7.
RESULTS

Population Risk Variables of the CDH Cohort
Outcomes of the CDH Cohort
The mortality rate for the 88 CDH patients admitted to network NICUs was 17% overall. In all, 11 CDH infants required ECMO (12.5%), and of these one died. The mean duration of NICU stay was 36.0±49.0 days, mean duration of assisted ventilation was 13.4±19.7 days, and mean duration of postventilation supplemental oxygen treatment was 7.7±20.4 days. At two of the four ECMO centers, the ECMO procedure was performed in the Pediatric Intensive Care Unit (PICU) and the patient was then transferred to the NICU for further care. Since our data does not include the length of hospitalization and mechanical ventilation in the PICU, these durations may have been underestimated. Table 2 shows the prediction of mortality among infants with CDH. Both SNAP-II and gestational age (continuous variables) were found to be predictive of outcome by bivariate analysis (SNAP-II: odd's ratio (OR) ¼ 1.057, 95% confidence interval (CI) ¼ 1.019 to 1.097; gestational age: OR ¼ 0.838, 95% CI ¼ 0.703 to 1.000).
Predictive Model for Outcomes of CDH Patients in the NICU
While SNAP-II predicted outcome concordantly (i.e. increase in SNAP-II score was associated with a higher likelihood of mortality F OR greater than 1), the prediction of mortality by gestational age was inversely related, with an OR of less than 1. Table 3 shows the predictive performance and goodness-of-fit of the different models for predicting mortality among infants with CDH. The model using SNAP-II alone performed better than that using gestational age alone for prediction of both mortality and need for ECMO. Predictive performance for mortality was similar and excellent for both the combined model (using SNAP-II and gestational age) and the CDHSG model, but goodness-of-fit was excellent for the combined model and only marginal for the CDHSG model. Figure 1 demonstrates that mortality rate increases consistently with SNAP-II scores expressed in quartiles.
Model Predictive Performance and Calibration
DISCUSSION
CDH remains an enigmatic birth defect. Despite improved prenatal diagnosis, enhanced understanding of disease pathophysiology and progress in neonatal intensive care including advanced ventilatory techniques, 7-9 inhaled nitric oxide, 10-12 ECMO, 13 variable timing of surgery [14] [15] [16] [17] [18] and even in utero surgery, [19] [20] [21] [22] there is little evidence to suggest that outcome from CDH has changed much over the past 20 years. 23 One factor that is essential for any study of outcomes related to a disease or condition of variable severity is the availability of a tool which permits stratification of patients according to the illness severity. The CDHSG, an international organization which collects and analyzes multi-institutional data on CDH patients from North America, Europe and Australia, has developed a ''probability of survival'' equation for CDH. In 2001, the CDHSG reported on a cohort of 1054 CDH patients, with an overall survival of 64%.
1 With survival as their single measured outcome, they evaluated a number of population-risk variables using logistic regression, and found that birth weight, 5-minute Apgar score, prenatal diagnosis of CDH, and respiratory distress present immediately at birth were significant predictors of outcome. From this, a ''probability of survival'' equation based on birth weight and 5-minute Apgar score was derived and tested against actual survival in CDH patient cohorts from the CDHSG, 1 the CNN, 24 as well as a cohort from a single pediatric institution. 25 The CDHSG's ''probability of survival'' equation allows risk stratification into terciles: low (0 to 33% predicted mortality); intermediate (34 to 66% predicted mortality); and high (67 to 100% predicted mortality). Although the equation correctly predicted outcome in one patient cohort, 1 it significantly underestimated actual survival in the other two (including that from the CNN).
In this study, we combined a validated physiologic measure of neonatal illness severity with traditional population-risk variables to assess CDH severity, and found that the resulting model predicted mortality as well as the CDHSG equation but with much better model calibration. Our results suggest that physiologic measures of illness severity are useful and valid not only for the general neonatal population but also for specific disease entities such as CDH.
One limitation of our study is the specificity of the ICD-10 diagnostic code which defines the study population. The code 456.6 refers to ''anomalies of the diaphragm'', which in the majority of cases would consist of a posterolateral (Bochdalek) defect with or without a hernia sac. However, this code would also be used to define diaphragmatic eventration and anterior diaphragmatic hernias of Morgagni, which although extremely rare neonatal diagnoses, are considered to be pathophysiologically distinct from Bochdalek hernias. In a manual chart review of our own institution's 5-year CNN cohort of neonatal CDH, we failed to identify any cases of diaphragmatic eventration or Morgagni hernia (unpublished data), yet the lack of absolute specificity of ICD-10 coding, and the impact this might have on the derivation of our risk variables, is an acknowledged limitation of our data set.
A limitation of any postnatal risk variable purported to predict outcome in CDH is that it is virtually impossible to identify a variable that is truly treatment independent. The frequency with which CDH is diagnosed prenatally means that the majority of affected infants with respiratory distress at birth will receive immediate supportive respiratory and/or cardiovascular care, so that even a relatively qualitative measure such as the 5-minute Apgar score will have been influenced by treatment. In spite of the fact that SNAP-II is measured over 12 hours following birth, its ability to quantitate physiologic derangement from norm in the areas of respiratory gas exchange, the systemic and pulmonary circulations and cellular oxygen delivery make it a good surrogate for the aggregate physiological derangement associated with pulmonary hypoplasia and pulmonary hypertension. Our current understanding of the importance of pulmonary vascular stabilization prior to surgical repair 26 may in fact favor a process of delayed risk stratification (such as that achieved by SNAP-II scoring), since it may not be the clinical symptoms present at birth, but rather the response to early supportive therapy that predicts outcome in CDH. Additional information about prenatal and perinatal risk factors might also improve model prediction, allow development of prenatal prognostic models, and permit differentiation of the relative contributions of perinatal, neonatal, and surgical care to overall outcome.
